A study analysing incidences of invasive pneumococcal disease after pneumococcal conjugate vaccine introduction in Europe and North America
Latest Information Update: 26 Feb 2021
At a glance
- Drugs Pneumococcal 10-valent vaccine conjugate (Primary) ; Pneumococcal 13-valent CRM197 vaccine conjugate (Primary) ; Pneumococcal 7-valent CRM197 vaccine conjugate (Primary)
- Indications Pneumococcal infections
- Focus Therapeutic Use
- 26 Feb 2021 New trial record
- 17 Feb 2021 Results published in the Vaccine